WENDY RINDAHL: Open Payments
NPI 1942881552 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 7 payments from 5 companies in 2025. Trend: 2023 $299 · 2024 $178 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $69 |
| Medtronic, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $15 |
Products named: AMVUTTRA, HAWKONE, ELIQUIS, Wegovy, OTEZLA.
Industry payments across TX — which companies pay providers there.
